Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,443 | 212 | 95.0% |
| Education | $182.15 | 3 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,707 | 122 | $0 (2024) |
| Janssen Biotech, Inc. | $490.73 | 20 | $0 (2024) |
| LEO Pharma Inc. | $406.62 | 18 | $0 (2024) |
| GENZYME CORPORATION | $279.59 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $276.13 | 15 | $0 (2023) |
| Lilly USA, LLC | $103.29 | 6 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $69.17 | 4 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $55.48 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $44.31 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $43.75 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.66 | 23 | ABBVIE INC. ($271.71) |
| 2023 | $610.26 | 35 | ABBVIE INC. ($305.77) |
| 2022 | $872.27 | 50 | ABBVIE INC. ($375.29) |
| 2021 | $707.05 | 39 | AbbVie Inc. ($316.19) |
| 2020 | $312.72 | 17 | AbbVie Inc. ($164.44) |
| 2019 | $247.24 | 14 | AbbVie, Inc. ($98.04) |
| 2018 | $242.20 | 20 | AbbVie, Inc. ($151.14) |
| 2017 | $272.32 | 17 | Novartis Pharmaceuticals Corporation ($59.99) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: DERMATOLOGY | ||||||
| 04/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Immunology | ||||||
| 02/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: IMMUNOLOGY | ||||||
| 02/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Immunology | ||||||
| 01/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 14,311 | 21,993 | $4.9M | $1.0M |
| 2022 | 26 | 14,053 | 23,008 | $4.8M | $1.0M |
| 2021 | 27 | 13,825 | 22,524 | $4.6M | $1.0M |
| 2020 | 30 | 13,107 | 21,420 | $3.2M | $933,424 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 10,945 | 16,627 | $3.8M | $806,248 | 21.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 478 | 621 | $228,436 | $50,783 | 22.2% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2023 | 63 | 316 | $121,660 | $28,429 | 23.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 789 | 915 | $125,631 | $26,907 | 21.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 327 | 346 | $111,425 | $25,179 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 377 | 452 | $134,244 | $21,919 | 16.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 150 | 336 | $89,739 | $21,001 | 23.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 212 | 225 | $85,050 | $14,775 | 17.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 277 | 316 | $70,468 | $9,559 | 13.6% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2023 | 63 | 63 | $31,626 | $7,103 | 22.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 231 | 1,257 | $28,911 | $6,030 | 20.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 87 | 94 | $31,772 | $4,916 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 58 | $24,360 | $4,248 | 17.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 61 | 68 | $18,350 | $4,115 | 22.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 25 | 26 | $14,612 | $3,047 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $11,439 | $1,446 | 12.6% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Office | 2023 | 99 | 113 | $6,102 | $1,311 | 21.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 19 | $3,192 | $732.30 | 22.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 16 | 16 | $4,864 | $707.61 | 14.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 94 | $2,256 | $68.44 | 3.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 9,712 | 14,696 | $3.2M | $705,832 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 630 | 1,032 | $304,440 | $59,753 | 19.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 462 | 550 | $199,162 | $43,227 | 21.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 396 | 526 | $196,724 | $40,101 | 20.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 312 | 325 | $102,846 | $23,722 | 23.1% |
About Dr. Bradley Graham, MD
Dr. Bradley Graham, MD is a Dermatology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083641062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Graham, MD has received a total of $3,625 in payments from pharmaceutical and medical device companies, with $360.66 received in 2024. These payments were reported across 215 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,443).
As a Medicare-enrolled provider, Graham has provided services to 55,296 Medicare beneficiaries, totaling 88,945 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Tyler, TX
- Active Since 06/27/2006
- Last Updated 05/22/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1083641062
Products in Payments
- SKYRIZI (Biological) $883.50
- TREMFYA (Drug) $489.51
- RINVOQ (Biological) $481.22
- Humira (Biological) $262.55
- ENSTILAR (Drug) $232.04
- DUPIXENT (Biological) $228.54
- COSENTYX (Biological) $157.61
- ADBRY (Biological) $132.88
- TALTZ (Drug) $103.29
- BLU-U (Medical Supply) $55.48
- DUPIXENT DUPILUMAB INJECTION (Biological) $51.98
- DUPIXENT (Drug) $51.05
- HUMIRA (Biological) $46.62
- REMICADE (Biological) $34.76
- Enbrel (Biological) $29.20
- Sotyktu (Drug) $28.90
- PICATO (Drug) $24.37
- Seysara (Drug) $22.55
- VTAMA (Drug) $20.67
- COSENTYX (Drug) $19.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Tyler
Jennifer Holman, Md, MD
Dermatology — Payments: $705,235
Lindsey Hunter-Ellul, Md, MD
Dermatology — Payments: $11,358
Martha Mccollough, Md, MD
Dermatology — Payments: $10,842
Leslie Markle, Md, MD
Dermatology — Payments: $8,660
Alma Berlingeri Ramos, Md, MD
Dermatology — Payments: $4,757
Jeffrey Harbold, Do, DO
Dermatology — Payments: $4,013